Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirinMohammed Faruk, Cheh Agustin Awasum, Rakiya Saidu et al.|PLoS ONE|2021Cited by 18
Abstract 720: Aspirin plus FOLFOX for colorectal cancer management: A promising alternative for clinical trial in Africans with the diseaseMohammed Faruk, Dauda Maigatari, Sani Ibrahim et al.|Molecular and Cellular Biology / Genetics|2019Cited by 0
Abstract 862: Transcriptomics analysis reveals unique immunoinflammatory signatures of nigerian prostate cancerSolomon O. Rotimi, Zarko Manojlovic, Abidemi Omonisi et al.|Cancer Research|2021Cited by 0
Abstract 720: Aspirin plus FOLFOX for colorectal cancer management: A promising alternative for clinical trial in Africans with the diseaseMohammed Faruk, Dauda Maigatari, Sani Ibrahim et al.|Cancer Research|2019Cited by 0
Abstract 6432: Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and low expression of BAZ1B and KMT2D is associated with early detection and poor prognosis of prostate cancer in African Black men from NigeriaMohammed Faruk, Sani Ibrahim, Konrad Stawiski et al.|Cancer Research|2024Cited by 0